Introduction
Vitiligo, vitiligo, atopic dermatitis, psoriasis
VITILIGO, VITILIGO, ATOPIC DERMATITIS, PSORIASIS
Vitiligo affects 2% of the world’s population with significant impact on health related quality of life (HRQoL) [When EQ-5D utilities are not collected, alternative methods such as ‘mapping’ may be used [There are several CSMs used for vitiligo patients. The dermatology life quality index (DLQI) is a 10-item validated questionnaire to measure how much the skin problem has affected patients [The VIS [Currently, no mapping algorithm exists in a vitiligo specific population, although several are published in psoriasis or atopic dermatitis [We use data from the HI-Light trial [Utilities from two currently used crosswalks: Van Hout et al., (2012) [